title: Reply to T. Radivoyevitch et al.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Guillermo
authors.initials: G
authors.lastname: Garcia-Manero
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D001374:Azacitidine / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine